<VariationArchive RecordType="classified" VariationID="30433" VariationName="NM_015713.5(RRM2B):c.965dup (p.Asn322fs)" VariationType="Duplication" Accession="VCV000030433" Version="4" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-10-08" DateCreated="2015-03-24" MostRecentSubmission="2022-10-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="39390" VariationID="30433">
      <GeneList>
        <Gene Symbol="RRM2B" FullName="ribonucleotide reductase regulatory TP53 inducible subunit M2B" GeneID="50484" HGNC_ID="HGNC:17296" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="102204501" stop="102238961" display_start="102204501" display_stop="102238961" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="103216728" stop="103251345" display_start="103216728" display_stop="103251345" Strand="-" />
          </Location>
          <OMIM>604712</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_015713.5(RRM2B):c.965dup (p.Asn322fs)</Name>
      <CanonicalSPDI>NC_000008.11:102208223:TTT:TTTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="102208223" stop="102208224" display_start="102208223" display_stop="102208224" variantLength="1" positionVCF="102208223" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="103220451" stop="103220452" display_start="103220451" display_stop="103220452" variantLength="1" positionVCF="103220451" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
      </Location>
      <ProteinChange>N394fs</ProteinChange>
      <ProteinChange>N270fs</ProteinChange>
      <ProteinChange>N322fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_788" sequenceAccession="LRG_788">
            <Expression>LRG_788:g.35895dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_788t1" sequenceAccession="LRG_788t1">
            <Expression>LRG_788t1:c.1181dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_788p1" sequenceAccession="LRG_788p1" change="p.Asn394fs">
            <Expression>LRG_788p1:p.Asn394fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015713.4" sequenceAccession="NM_015713" sequenceVersion="4" change="c.965dupA">
            <Expression>NM_015713.4:c.965dupA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.103220454dup" Assembly="GRCh37">
            <Expression>NC_000008.10:g.103220454dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.102208226dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.102208226dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016617.1" sequenceAccession="NG_016617" sequenceVersion="1" change="g.35895dup">
            <Expression>NG_016617.1:g.35895dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172477.1" sequenceAccession="NM_001172477" sequenceVersion="1" change="c.1181dup">
            <Expression>NM_001172477.1:c.1181dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165948.1" sequenceAccession="NP_001165948" sequenceVersion="1" change="p.Asn394fs">
            <Expression>NP_001165948.1:p.Asn394fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172478.2" sequenceAccession="NM_001172478" sequenceVersion="2" change="c.809dup">
            <Expression>NM_001172478.2:c.809dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165949.1" sequenceAccession="NP_001165949" sequenceVersion="1" change="p.Asn270fs">
            <Expression>NP_001165949.1:p.Asn270fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015713.5" sequenceAccession="NM_015713" sequenceVersion="5" change="c.965dup" MANESelect="true">
            <Expression>NM_015713.5:c.965dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056528.2" sequenceAccession="NP_056528" sequenceVersion="2" change="p.Asn322fs">
            <Expression>NP_056528.2:p.Asn322fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA213027" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="604712.0011" DB="OMIM" />
        <XRef Type="rs" ID="515726201" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015713.5(RRM2B):c.965dup (p.Asn322fs) AND Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5" Accession="RCV000023386" Version="6">
        <ClassifiedConditionList TraitSetID="1506">
          <ClassifiedCondition DB="MedGen" ID="C2751319">Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-06-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015713.5(RRM2B):c.965dup (p.Asn322fs) AND RRM2B-related mitochondrial disease" Accession="RCV000119015" Version="4">
        <ClassifiedConditionList TraitSetID="13737">
          <ClassifiedCondition DB="MedGen" ID="CN187502">RRM2B-related mitochondrial disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-06-07" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-03-24" MostRecentSubmission="2022-10-01">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21646632</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">24741716</ID>
          <ID Source="BookShelf">NBK195854</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13737" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="18761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">RRM2B-related mitochondrial disease</ElementValue>
              </Name>
              <XRef ID="CN187502" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1506" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6823" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">RRM2B-Related Chronic Progressive External Ophthalmoplegia with Multiple mtDNA Deletions</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Chronic Progressive External Ophthalmoplegia with Multiple mtDNA Deletions</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 5</ElementValue>
                <XRef Type="MIM" ID="613077" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5</ElementValue>
                <XRef ID="MONDO:0013117" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PEOA5</ElementValue>
                <XRef Type="MIM" ID="613077" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Four phenotypes comprise the RRM2B mitochondrial DNA maintenance defects (RRM2B-MDMDs): RRM2B encephalomyopathic MDMD, the most severe phenotype, usually manifesting shortly after birth as hypotonia, poor feeding, and faltering growth requiring hospitalization. Subsequent assessments are likely to reveal multisystem involvement including sensorineural hearing loss, renal tubulopathy, and respiratory failure. Autosomal dominant progressive external ophthalmoplegia (adPEO), typically adult onset; other manifestations can include ptosis, bulbar dysfunction, fatigue, and muscle weakness. RRM2B autosomal recessive progressive external ophthalmoplegia (arPEO), a typically childhood-onset predominantly myopathic phenotype of PEO, ptosis, proximal muscle weakness, and bulbar dysfunction. RRM2B mitochondrial neurogastrointestinal encephalopathy (MNGIE)-like, characterized by progressive ptosis, ophthalmoplegia, gastrointestinal dysmotility, cachexia, and peripheral neuropathy. To date, 78 individuals from 52 families with a molecularly confirmed RRM2B-MDMD have been reported.</Attribute>
                <XRef ID="NBK195854" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24741716</ID>
                <ID Source="BookShelf">NBK195854</ID>
              </Citation>
              <XRef ID="C2751319" DB="MedGen" />
              <XRef ID="MONDO:0013117" DB="MONDO" />
              <XRef Type="MIM" ID="613077" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="278504" SubmissionDate="2021-08-23" DateLastUpdated="2022-10-01" DateCreated="2014-05-31">
        <ClinVarSubmissionID localKey="NM_015713.4:c.965dupA|MedGen:CN187502" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000153713" DateUpdated="2022-10-01" DateCreated="2014-05-31" Type="SCV" Version="4" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation Type="general">
            <ID Source="BookShelf">NBK195854</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015713.4:c.965dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN187502" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Abbrev="GeneReviews" Type="review">
          <ID Source="PubMed">24741716</ID>
          <ID Source="BookShelf">NBK195854</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB10237106</SubmissionName>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="49933" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604712.0011_PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5" title="RRM2B, 1-BP DUP, 965A_PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5" />
        <ClinVarAccession Accession="SCV000044677" DateUpdated="2021-01-01" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-06-07">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 unrelated patients with autosomal dominant progressive external ophthalmoplegia-5 (PEOA5; 613077), Fratter et al. (2011) identified a heterozygous 1-bp duplication (965dupA) in the RRM2B gene, resulting in a frameshift and premature termination. The patients had onset at ages 30, 54, and 26 years, and all had a family history of the disorder. All had PEO and fatigue, but additional features were variable and included diabetes, gastrointestinal symptoms, dysphagia, dysphonia, and proximal myopathy. Skeletal muscle biopsies of the probands showed a mosaic defect of cytochrome c oxidase activity and multiple mtDNA deletions. The mutation was not found in 352 control alleles.</Attribute>
              <Citation>
                <ID Source="PubMed">21646632</ID>
              </Citation>
              <XRef DB="OMIM" ID="613077" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RRM2B" />
          </GeneList>
          <Name>RRM2B, 1-BP DUP, 965A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 965A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604712.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="278504" TraitType="Disease" MappingType="XRef" MappingValue="CN187502" MappingRef="MedGen">
        <MedGen CUI="CN187502" Name="RRM2B-related mitochondrial disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="49933" TraitType="Disease" MappingType="Name" MappingValue="PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5" MappingRef="Preferred">
        <MedGen CUI="C2751319" Name="Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

